Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hickman

Showing results (31-40 of 519) with videos related to

Pageof 52
Sort By:
Bulletin of the World Health Organization|April 5, 2013
Mitigating the risk of HIV infection with opioid substitution treatmentLinda R Gowing, Matthew Hickman, Louisa Degenhardt
Social Psychiatry and Psychiatric Epidemiology|March 5, 2022
An ecological study of temporal trends in 'deaths of despair' in England and WalesElizabeth Augarde, David Gunnell, Becky Mars, et al.
BMJ (Clinical Research Ed.)|July 15, 2010
Policy resistance to harm reduction for drug users and potential effect of changeTim Rhodes, Anya Sarang, Peter Vickerman, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 26, 2014
Case-finding for hepatitis C in primary care: a mixed-methods service evaluationShivani Datta, Jeremy Horwood, Matthew Hickman, et al.
Addiction (Abingdon, England)|May 9, 2012
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settingsPeter Vickerman, Natasha Martin, Katy Turner, et al.
Addiction (Abingdon, England)|November 12, 2014
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Peter Vickerman, Kimberly Page, Lisa Maher, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Assessing the public health effects of cannabis use: can legalization improve the evidence base?Matthew Hickman, Lindsey A Hines, Suzie H Gage
The International Journal on Drug Policy|July 29, 2021
Mapping drug epidemiology futuresSarah Larney, Hannah Jones, Tim Rhodes, et al.
The Lancet. Digital Health|May 28, 2021
Big data and predictive modelling for the opioid crisis: existing research and future potentialChrianna Bharat, Matthew Hickman, Sebastiano Barbieri, et al.
BMJ Open|May 22, 2018
Adolescent self-consent for vaccinations: protocol for a mixed methods systematic reviewHarriet Fisher, Matthew Hickman, John Macleod, et al.
Pageof 52

Showing results (31-40 of 519) with videos related to

Sort By:
Pageof 52
Bulletin of the World Health Organization|April 5, 2013
Mitigating the risk of HIV infection with opioid substitution treatmentLinda R Gowing, Matthew Hickman, Louisa Degenhardt
Social Psychiatry and Psychiatric Epidemiology|March 5, 2022
An ecological study of temporal trends in 'deaths of despair' in England and WalesElizabeth Augarde, David Gunnell, Becky Mars, et al.
BMJ (Clinical Research Ed.)|July 15, 2010
Policy resistance to harm reduction for drug users and potential effect of changeTim Rhodes, Anya Sarang, Peter Vickerman, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 26, 2014
Case-finding for hepatitis C in primary care: a mixed-methods service evaluationShivani Datta, Jeremy Horwood, Matthew Hickman, et al.
Addiction (Abingdon, England)|May 9, 2012
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settingsPeter Vickerman, Natasha Martin, Katy Turner, et al.
Addiction (Abingdon, England)|November 12, 2014
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Peter Vickerman, Kimberly Page, Lisa Maher, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Assessing the public health effects of cannabis use: can legalization improve the evidence base?Matthew Hickman, Lindsey A Hines, Suzie H Gage
The International Journal on Drug Policy|July 29, 2021
Mapping drug epidemiology futuresSarah Larney, Hannah Jones, Tim Rhodes, et al.
The Lancet. Digital Health|May 28, 2021
Big data and predictive modelling for the opioid crisis: existing research and future potentialChrianna Bharat, Matthew Hickman, Sebastiano Barbieri, et al.
BMJ Open|May 22, 2018
Adolescent self-consent for vaccinations: protocol for a mixed methods systematic reviewHarriet Fisher, Matthew Hickman, John Macleod, et al.
Pageof 52